USANA Health Sciences USNA Southeast Asia Pacific — Net Sales
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by USANA Health Sciences in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about USANA Health Sciences's southeast asia pacific — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is USANA Health Sciences's southeast asia pacific — net sales?
- USANA Health Sciences (USNA) reported southeast asia pacific — net sales of $30.66M in Q1 2026.
- How has USANA Health Sciences's southeast asia pacific — net sales changed year-over-year?
- USANA Health Sciences's southeast asia pacific — net sales decreased by 14.2% year-over-year, from $35.72M to $30.66M.
- What is the long-term trend for USANA Health Sciences's southeast asia pacific — net sales?
- Over 4 years (2021 to 2025), USANA Health Sciences's southeast asia pacific — net sales has grown at a -16.4% compound annual growth rate (CAGR), from $269.8M to $132M.
- What does southeast asia pacific — net sales mean?
- This metric represents the total revenue generated from the sale of nutritional and personal-care products within the Southeast Asia Pacific geographic region. It serves as a key indicator of the company's market penetration, brand demand, and the effectiveness of its direct selling model in this specific territory. Tracking this figure helps investors assess regional growth trends and the impact of local economic conditions on the company's top-line performance.